IDH1 and central nervous system cancer: However, its regulatory mechanism in glioma remains incompletely understood.<h4>Results</h4>miR-182-5p expression was increased within IDH1-mutant glioma specimens according to TCGA, CGGA, and online dataset GSE119740, as well as collected clinical samples.